Signal active
Organization
Contact Information
Overview
Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients. Orca Bio has developed a pipeline of proprietary technologies that have the potential to impact over 100 malignant and auto-immune diseases. Orca has assembled a team of world-leading experts and technologists to execute this vision.
About
Health Care, Pharmaceutical, Medical
2016
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Orca Bio headquartered in United States, North America, operates in the Health Care, Pharmaceutical, Medical sector. The company focuses on Health Care and has secured $6.9B in funding across 36 round(s). With a team of 101-250 employees, Orca Bio is actively contributing to advancements in Health Care. Their latest funding round, Pre Seed Round - Orca Bio, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
3
1
0
$192.0M
Details
3
Orca Bio has raised a total of $192.0M in funding over 3 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2020 | Late Stage Venture | 192.0M | ||
2018 | Late Stage Venture | |||
2016 | Seed |
Investors
Orca Bio is funded by 17 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Dream Variation Ventures | - | FUNDING ROUND - Dream Variation Ventures | 192.0M |
DCVC Bio | - | FUNDING ROUND - DCVC Bio | undefined |
Orca Bio | - | FUNDING ROUND - Orca Bio | undefined |
Ling Wong | - | FUNDING ROUND - Ling Wong | undefined |
Recent Activity
There is no recent news or activity for this profile.